GlassScriptPhysician profile
Ashlie Morrissey
NPI 1710339270
$1,178.90
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,023 · 2022: $23.00 · 2024: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $463.66 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $133.15 | 2024 | Rexulti |
| Abbvie INC. | $79.05 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $66.34 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $41.00 | 2021 | |
| Sunovion Pharmaceuticals INC. | $35.24 | 2021 | |
| Allergan, INC. | $26.65 | 2021 | |
| Amgen INC. | $25.12 | 2021 | |
| Harmony Biosciences LLC | $23.00 | 2022 | |
| Acorda Therapeutics, INC | $21.67 | 2021 | |
| Banner Life Sciences, LLC | $20.21 | 2021 | |
| Kyowa Kirin, INC. | $19.20 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.09 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.79 | 2021 | |
| Genzyme Corporation | $18.23 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $18.12 | 2021 | |
| Ucb, INC. | $17.50 | 2021 | |
| Integra Lifesciences Corporation | $16.95 | 2021 | |
| Lundbeck LLC | $16.02 | 2021 | |
| Adamas Pharmaceuticals, INC. | $16.00 | 2021 | |
| Genentech USA, INC. | $15.41 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.99 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.60 | 2021 | |
| Biogen, INC. | $14.06 | 2021 | |
| Eisai INC. | $13.48 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlie Morrissey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.